Conversely to it, several studies have shown that AhR activation by endogenous or exogenous ligands leads to increased tumor-cell migration and aggressiveness in breast cancer [28,29] and lung-cancer cell lines exposed to kynurenine [30] and benzo(a)pyrene (BaP) [31,32]. This evidence concerns the gene AHR and breast carcinoma.